HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pound, E. M. Articles by Leaf, A. Search for Related Content PubMed PubMed Citation Articles by Pound, E. M. Articles by Leaf, A. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 42, 346-351, March 2001
Copyright © 2001 by Lipid Research, Inc.

Original Article

Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes

Correspondence to: A. Leaf, at Massachussetts General Hospital–East, Bldg. 149, Room 4001, 13th St., Charlestown, MA 02129., aleaf{at}partners.org (E-mail)

It has been demonstrated in animal studies that polyunsaturated fatty acids (PUFA) prevent ischemia-induced malignant ventricular arrhythmias, a major cause of sudden cardiac death in humans. To learn how these PUFA, at low micromolar concentrations, exert their antiarrhythmic activity, we studied their effects in vitro on the contractions of isolated cardiac myocytes and the conductances of their sarcolemmal ion channels. These fatty acids directly stabilize electrically every cardiac myocyte by modulating the conductances of specific ion channels in their sarcolemma. In this study, we determined the molar ratio of PUFA to the moles of phospholipid (PL) in cell membranes to learn if the ratio is so low as to preclude the possibility that the primary site of action of PUFA is on the packing of the membrane PL. [³H]-arachidonic acid (AA) was used to measure the incorporation of PUFA, and the inorganic phosphorous of the PL was determined as a measure of the moles of PL in the cell membrane. Our results indicate that the mole percent of AA to moles of phospolipid is very low (1.0) at the concentrations that affect myocyte contraction and the conductance of voltage-dependent Na⁺ and L-type Ca²+ channels in rat cardiomyocytes and in -subunits of human myocardial Na⁺ channels.

In conclusion, it seems highly unlikely that these fatty acids are affecting the packing of PL within cell membranes as their way of modulating changes in cell membrane ion currents and in preventing arrhythmias in our contractility studies. — Pound, E. M., J. X. Kang, and A. Leaf. Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. J. Lipid Res. 2001. 42: 346;–351.

Supplementary key words: eicosapentaenoic acid, docosahexaenoic acid, arachidonic acid, fish oil, sudden cardiac death

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. C. DeMar Jr., C. DiMartino, A. W. Baca, W. Lefkowitz, and N. Salem Jr. Effect of dietary docosahexaenoic acid on biosynthesis of docosahexaenoic acid from alpha-linolenic acid in young rats J. Lipid Res., September 1, 2008; 49(9): 1963 - 1980. [Abstract] [Full Text] [PDF]

				S. J. Liu Inhibition of L-type Ca2+ channel current and negative inotropy induced by arachidonic acid in adult rat ventricular myocytes Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1594 - C1604. [Abstract] [Full Text] [PDF]

				M.S. Kostapanos, E.N. Liberopoulos, J.A. Goudevenos, D.P. Mikhailidis, and M.S. Elisaf Do statins have an antiarrhythmic activity? Cardiovasc Res, July 1, 2007; 75(1): 10 - 20. [Abstract] [Full Text] [PDF]

				M. J. Bruno, R. E. Koeppe II, and O. S. Andersen Docosahexaenoic acid alters bilayer elastic properties PNAS, June 5, 2007; 104(23): 9638 - 9643. [Abstract] [Full Text] [PDF]

				H. M. Den Ruijter, G. Berecki, T. Opthof, A. O. Verkerk, P. L. Zock, and R. Coronel Pro- and antiarrhythmic properties of a diet rich in fish oil Cardiovasc Res, January 15, 2007; 73(2): 316 - 325. [Abstract] [Full Text] [PDF]

				G. Patti, M. Chello, D. Candura, V. Pasceri, A. D'Ambrosio, E. Covino, and G. Di Sciascio Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study Circulation, October 3, 2006; 114(14): 1455 - 1461. [Abstract] [Full Text] [PDF]

				Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF]

				V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF]

				V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF]

				A. K. Vyas, H. Guo, A. J. Moss, B. Olshansky, S. A. McNitt, W. J. Hall, W. Zareba, J. S. Steinberg, A. Fischer, J. Ruskin, et al. Reduction in Ventricular Tachyarrhythmias With Statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II J. Am. Coll. Cardiol., February 21, 2006; 47(4): 769 - 773. [Abstract] [Full Text] [PDF]

				W. Ulbricht Sodium Channel Inactivation: Molecular Determinants and Modulation Physiol Rev, October 1, 2005; 85(4): 1271 - 1301. [Abstract] [Full Text] [PDF]

				J.S Swan, K Dibb, N Negretti, S.C O'Neill, and R Sitsapesan Effects of eicosapentaenoic acid on cardiac SR Ca2+-release and ryanodine receptor function Cardiovasc Res, November 1, 2003; 60(2): 337 - 346. [Abstract] [Full Text] [PDF]

				L. B. Mitchell, J. L. Powell, A. M. Gillis, V. Kehl, A. P. Hallstrom, and the AVID Investigators Are lipid-lowering drugs also antiarrhythmic drugs?: an analysis of the antiarrhythmics versus implantable defibrillators (AVID) trial J. Am. Coll. Cardiol., July 2, 2003; 42(1): 81 - 87. [Abstract] [Full Text] [PDF]

				K.W. Lee and G.Y.H. Lip The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease QJM, July 1, 2003; 96(7): 465 - 480. [Abstract] [Full Text] [PDF]

				D. B. Jump The Biochemistry of n-3 Polyunsaturated Fatty Acids J. Biol. Chem., March 8, 2002; 277(11): 8755 - 8758. [Full Text] [PDF]

				M. Y Abeywardena and R. J Head Longchain n-3 polyunsaturated fatty acids and blood vessel function Cardiovasc Res, December 1, 2001; 52(3): 361 - 371. [Abstract] [Full Text] [PDF]